Regular intense training remodels the heart itself: the walls thicken, the cavity enlarges, and the ECG often shows high voltage. The same finding — a thick left ventricle — defines hypertrophic cardiomyopathy (HCM), and mild HCM can be difficult to separate from the athlete’s heart. The distinction matters at both ends. Missing HCM leaves a preventable risk of sudden death in place, while mislabelling a physiological heart excludes a healthy athlete from sport.
Features that separate them
The two conditions differ in where the thickening sits, how the chamber and atrium look, how the ventricle fills, and what happens when training stops (detraining).
| Feature | Athletic heart | HCM |
|---|---|---|
| Pattern | Diffuse, symmetric thickening | Segmental, asymmetric thickening |
| Cavity | Enlarged | Normal or reduced |
| Left atrium | Normal | Often enlarged from diastolic dysfunction |
| Diastolic function | Normal filling | Abnormal relaxation |
| Fibrosis on imaging | Absent | Present at the right ventricular insertion points, and patchy |
| ECG | Normal or voltage-only changes | Voltage plus deep negative T waves, axis shift, QRS disruption |
| Detraining | Thickness regresses after months off sport | Hypertrophy persists |
| Family history | Negative | May be positive, autosomal dominant |
| Exercise capacity | Normal or supranormal | Often reduced by diastolic limitation |
When the picture stays ambiguous
When doubt persists despite full testing, the traditional approach stops sport for 6 months and re-evaluates: regression favours athletic heart. In elite athletes who cannot pause, contrast-enhanced imaging plus genetic testing usually settles the question.
Once HCM is confirmed, attention turns to the outflow obstruction, which may need treatment, and to the arrhythmic risk that decides whether a defibrillator is discussed.